Filing Details

Accession Number:
0001104659-22-092960
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-19 16:06:01
Reporting Period:
2022-08-17
Accepted Time:
2022-08-19 16:06:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828185 Vaccitech Plc VACC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1851664 Christopher Ellis C/O Vaccitech Plc, Unit 6-10,
Zeus Building Rutherford Avenue, Harwell
Didcot X0 OX11 0DF
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-08-17 649 $0.00 724 No 4 M Direct
Ordinary Shares Disposition 2022-08-17 649 $4.77 75 No 4 S Direct
Ordinary Shares Acquisiton 2022-08-18 2,175 $0.00 2,250 No 4 M Direct
Ordinary Shares Disposition 2022-08-18 2,175 $4.84 75 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Share Option (Right to Buy) Disposition 2022-08-17 649 $0.00 649 $0.00
Ordinary Shares Share Option (Right to Buy) Disposition 2022-08-18 2,175 $0.00 2,175 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,781 2028-02-16 No 4 M Direct
40,606 2028-02-16 No 4 M Direct
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.18 - $4.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.